IGM BIOSCIENCES INC. - COMMON STOCK

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

08 5 2024 16:10:00 提供 Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference

07 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

IGM Biosciences Announces Refocusing of Sanofi Collaboration

17 4 2024 08:30:58 提供 Nasdaq GlobeNewswire

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

10 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

07 3 2024 16:10:00 提供 Nasdaq GlobeNewswire

IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 1 2024 07:00:00 提供 Nasdaq GlobeNewswire

IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension

05 12 2023 16:01:00 提供 Nasdaq GlobeNewswire

IGM Biosciences Announces Third Quarter 2023 Financial Results

13 11 2023 16:10:00 提供 Nasdaq GlobeNewswire

IGM Biosciences to Present at Two Upcoming Investor Conferences

07 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors

03 10 2023 16:05:00 提供 Nasdaq GlobeNewswire

IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

06 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

IGM Biosciences Announces Second Quarter 2023 Financial Results

03 8 2023 16:10:00 提供 Nasdaq GlobeNewswire

IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

03 7 2023 16:01:00 提供 Nasdaq GlobeNewswire

IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement

22 6 2023 07:58:50 提供 Nasdaq GlobeNewswire

IGM Announces Proposed Public Offering and Concurrent Private Placement

21 6 2023 17:17:00 提供 Nasdaq GlobeNewswire

IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development

02 6 2023 17:30:00 提供 Nasdaq GlobeNewswire

IGM Biosciences to Present at the Jefferies Healthcare Conference

01 6 2023 07:00:00 提供 Nasdaq GlobeNewswire

IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis

31 5 2023 07:00:00 提供 Nasdaq GlobeNewswire

IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update

30 5 2023 07:00:00 提供 Nasdaq GlobeNewswire